Cost of Treating Sagittal Synostosis in the First Year of Life

被引:54
作者
Abbott, Megan M. [1 ,2 ,3 ]
Rogers, Gary F. [1 ,2 ]
Proctor, Mark R. [2 ,4 ]
Busa, Kathleen [1 ]
Meara, John G. [1 ,2 ]
机构
[1] Childrens Hosp Boston, Dept Plast & Oral Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA
[4] Childrens Hosp Boston, Dept Neurosurg, Boston, MA 02115 USA
关键词
Craniosynostosis; sagittal; endoscopic; cost analysis; cranial vault remodeling; ENDOSCOPIC CRANIECTOMY; MOLDING THERAPY; CRANIOSYNOSTOSIS; MANAGEMENT;
D O I
10.1097/SCS.0b013e318240f965
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Endoscopically assisted suturectomy (EAS) has been reported to reduce the morbidity and cost of treating sagittal synostosis when compared with traditional open cranial vault remodeling (CVR) procedures. Whereas the former claim is well substantiated and intuitive, the latter has not been validated by rigorous cost analysis. Methods: Patient medical records and financial database reports were culled retrospectively to determine the total cost associated with both EAS and CVR during 1 year of care. Recorded cost data included physician and hospital services, orthotic equipment and fittings, and indirect patient cost. Results: Ten patients treated with CVR were compared with 10 patients who underwent EAS. The CVR patients incurred greater costs in nearly all categories studied, including overall 1-year costs, physician services, hospital services, supplies/equipment, medications/intravenous fluids, and laboratory and blood bank services. Postoperative costs were greater in the EAS group, primarily because of the cost associated with orthotic services and indirect patient costs for travel and lost work. However, overall indirect patient costs for the whole year did not differ between the groups. One-year median costs were $55,121 for CVR and $23,377 for EAS. Early clinical results were similar for the 2 groups. Conclusions: Cranial vault remodeling was more costly in the first year of treatment than EAS, although indirect patient costs were similar. The favorable cost of EAS compared with CVR provides further justification to consider this procedure as first-line treatment of sagittal synostosis in young infants.
引用
收藏
页码:88 / 93
页数:6
相关论文
共 13 条